Literature DB >> 7806390

Analysis of expression of CagA and VacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that CagA is not necessary for expression of the vacuolating cytotoxin.

Z Xiang1, S Censini, P F Bayeli, J L Telford, N Figura, R Rappuoli, A Covacci.   

Abstract

Colonization of the mucosa of the stomach and the duodenum by Helicobacter pylori is the major cause of acute and chronic gastroduodenal pathologies in humans. Duodenal ulcer formation strongly correlates with the expression of an antigen (CagA) that is usually coeexpressed with the vacuolating cytotoxin (VacA), a protein that causes ulceration in the stomach of mice. However, the relationship between these two virulence factors is unknown. To define whether CagA and VacA are coexpressed in all clinical isolates and their relationships, we collected 43 clinical isolates of H. pylori and studied their genetic and phenotypic properties. Based on this analysis, most of the strains could be classified into two major types. Type I bacteria had the gene coding for CagA and expressed the CagA protein and the vacuolating cytotoxin. Type II bacteria did not have the gene coding for CagA and did not express either the CagA protein or the vacuolating cytotoxin. Type I and type II bacteria represented 56 and 16%, respectively, of the 43 clinical isolates, while the remaining 28% had an intermediate phenotype, expressing CagA independently of VacA or vice versa. This finding shows that although it is present in most cytotoxic strains, CagA is not necessary for the expression of the vacuolating cytotoxin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7806390      PMCID: PMC172962          DOI: 10.1128/iai.63.1.94-98.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

Review 1.  Helicobacter pylori: microbiology of a 'slow' bacterial infection.

Authors:  M J Blaser
Journal:  Trends Microbiol       Date:  1993-10       Impact factor: 17.079

2.  Detection in an enzyme immunoassay of an immune response to a recombinant fragment of the 128 kilodalton protein (CagA) of Helicobacter pylori.

Authors:  Z Xiang; M Bugnoli; A Ponzetto; A Morgando; N Figura; A Covacci; R Petracca; C Pennatini; S Censini; D Armellini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-10       Impact factor: 3.267

3.  Mutation of the cytotoxin-associated cagA gene does not affect the vacuolating cytotoxin activity of Helicobacter pylori.

Authors:  M K Tummuru; T L Cover; M J Blaser
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

4.  Pathological significance and molecular characterization of the vacuolating toxin gene of Helicobacter pylori.

Authors:  S H Phadnis; D Ilver; L Janzon; S Normark; T U Westblom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

5.  Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene.

Authors:  C Spiegelhalder; B Gerstenecker; A Kersten; E Schiltz; M Kist
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

6.  Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.

Authors:  T Borén; P Falk; K A Roth; G Larson; S Normark
Journal:  Science       Date:  1993-12-17       Impact factor: 47.728

7.  Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains.

Authors:  T L Cover; M K Tummuru; P Cao; S A Thompson; M J Blaser
Journal:  J Biol Chem       Date:  1994-04-08       Impact factor: 5.157

8.  Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity.

Authors:  T L Cover; C P Dooley; M J Blaser
Journal:  Infect Immun       Date:  1990-03       Impact factor: 3.441

9.  Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer.

Authors:  A Covacci; S Censini; M Bugnoli; R Petracca; D Burroni; G Macchia; A Massone; E Papini; Z Xiang; N Figura
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease.

Authors:  J L Telford; P Ghiara; M Dell'Orco; M Comanducci; D Burroni; M Bugnoli; M F Tecce; S Censini; A Covacci; Z Xiang
Journal:  J Exp Med       Date:  1994-05-01       Impact factor: 14.307

View more
  184 in total

1.  Analysis of Helicobacter pylori vacA gene and serum antibodies to VacA in Japan.

Authors:  D Shirasaka; N Aoyama; K Satonaka; K Shirakawa; H Yoshida; T Sakai; T Ikemura; Y Shinoda; M Sakashita; M Miyamoto; K Yahiro; A Wada; H Kurazono; T Hirayama; M Kasuga
Journal:  Dig Dis Sci       Date:  2000-04       Impact factor: 3.199

2.  Molecular characterization of two-component systems of Helicobacter pylori.

Authors:  D Beier; R Frank
Journal:  J Bacteriol       Date:  2000-04       Impact factor: 3.490

3.  Mutational analysis of the Helicobacter pylori vacuolating toxin amino terminus: identification of amino acids essential for cellular vacuolation.

Authors:  D Ye; S R Blanke
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

4.  Cloning of fibA, encoding an immunogenic subunit of the fibril-like surface structure of Peptostreptococcus micros.

Authors:  B H Kremer; J J Bijlsma; J G Kusters; J de Graaff; T J van Steenbergen
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

Review 5.  Extradigestive manifestations of Helicobacter pylori infection: fact and fiction.

Authors:  G Realdi; M P Dore; L Fastame
Journal:  Dig Dis Sci       Date:  1999-02       Impact factor: 3.199

6.  Detection of serum antibodies to CagA and VacA and of serum neutralizing activity for vacuolating cytotoxin in patients with Helicobacter pylori-induced gastritis.

Authors:  M Donati; S Moreno; E Storni; A Tucci; L Poli; C Mazzoni; O Varoli; V Sambri; A Farencena; R Cevenini
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

7.  Platelet activation In mice and human Helicobacter pylori infection.

Authors:  J I Elizalde; J Gómez; J Panés; M Lozano; M Casadevall; J Ramírez; P Pizcueta; F Marco; F D Rojas; D N Granger; J M Piqué
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 8.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

Review 9.  Structural and functional aspects of the Helicobacter pylori secretome.

Authors:  Giuseppe Zanotti; Laura Cendron
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

10.  Growth phase-dependent regulation of target gene promoters for binding of the essential orphan response regulator HP1043 of Helicobacter pylori.

Authors:  Isabel Delany; Gunther Spohn; Rino Rappuoli; Vincenzo Scarlato
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.